Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity

Michael B. Harbut, Baiyuan Yang, Renhe Liu, Takahiro Yano, Catherine Vilchèze, Bo Cheng, Jonathan Lockner, Hui Guo, Chenguang Yu, Scott G. Franzblau, H. Mike Petrassi, William R. Jacobs, Harvey Rubin, Arnab K. Chatterjee, Feng Wang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The generation of ATP through oxidative phosphorylation is an essential metabolic function for Mycobaterium tuberculosis (Mtb), regardless of the growth environment. The type II NADH dehydrogenase (Ndh-2) is the conduit for electrons into the pathway, and is absent in the mammalian genome, thus making it a potential drug target. Herein, we report the identification of two types of small molecules as selective inhibitors for Ndh-2 through a multicomponent high-throughput screen. Both compounds block ATP synthesis, lead to effects consistent with loss of NADH turnover, and importantly, exert bactericidal activity against Mtb. Extensive medicinal chemistry optimization afforded the best analogue with an MIC of 90 nm against Mtb. Moreover, the two scaffolds have differential inhibitory activities against the two homologous Ndh-2 enzymes in Mtb, which will allow precise control over Ndh-2 function in Mtb to facilitate the assessment of this anti-TB drug target.

Original languageEnglish (US)
Pages (from-to)3478-3482
Number of pages5
JournalAngewandte Chemie - International Edition
Volume57
Issue number13
DOIs
StatePublished - Mar 19 2018

Fingerprint

Adenosinetriphosphate
Adenosine Triphosphate
Molecules
Scaffolds
Pharmaceutical Preparations
NAD
Enzymes
Genes
Throughput
Electrons
NADH dehydrogenase II
Oxidoreductases
Pharmaceutical Chemistry
Oxidative Phosphorylation

Keywords

  • antimicrobial compounds
  • drug discovery
  • Mycobaterium tuberculosis
  • Ndh-2
  • oxidative phosphorylation

ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)

Cite this

Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. / Harbut, Michael B.; Yang, Baiyuan; Liu, Renhe; Yano, Takahiro; Vilchèze, Catherine; Cheng, Bo; Lockner, Jonathan; Guo, Hui; Yu, Chenguang; Franzblau, Scott G.; Petrassi, H. Mike; Jacobs, William R.; Rubin, Harvey; Chatterjee, Arnab K.; Wang, Feng.

In: Angewandte Chemie - International Edition, Vol. 57, No. 13, 19.03.2018, p. 3478-3482.

Research output: Contribution to journalArticle

Harbut, MB, Yang, B, Liu, R, Yano, T, Vilchèze, C, Cheng, B, Lockner, J, Guo, H, Yu, C, Franzblau, SG, Petrassi, HM, Jacobs, WR, Rubin, H, Chatterjee, AK & Wang, F 2018, 'Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity', Angewandte Chemie - International Edition, vol. 57, no. 13, pp. 3478-3482. https://doi.org/10.1002/anie.201800260
Harbut, Michael B. ; Yang, Baiyuan ; Liu, Renhe ; Yano, Takahiro ; Vilchèze, Catherine ; Cheng, Bo ; Lockner, Jonathan ; Guo, Hui ; Yu, Chenguang ; Franzblau, Scott G. ; Petrassi, H. Mike ; Jacobs, William R. ; Rubin, Harvey ; Chatterjee, Arnab K. ; Wang, Feng. / Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. In: Angewandte Chemie - International Edition. 2018 ; Vol. 57, No. 13. pp. 3478-3482.
@article{8993a779743c46dab6902eaee7c9d69f,
title = "Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity",
abstract = "The generation of ATP through oxidative phosphorylation is an essential metabolic function for Mycobaterium tuberculosis (Mtb), regardless of the growth environment. The type II NADH dehydrogenase (Ndh-2) is the conduit for electrons into the pathway, and is absent in the mammalian genome, thus making it a potential drug target. Herein, we report the identification of two types of small molecules as selective inhibitors for Ndh-2 through a multicomponent high-throughput screen. Both compounds block ATP synthesis, lead to effects consistent with loss of NADH turnover, and importantly, exert bactericidal activity against Mtb. Extensive medicinal chemistry optimization afforded the best analogue with an MIC of 90 nm against Mtb. Moreover, the two scaffolds have differential inhibitory activities against the two homologous Ndh-2 enzymes in Mtb, which will allow precise control over Ndh-2 function in Mtb to facilitate the assessment of this anti-TB drug target.",
keywords = "antimicrobial compounds, drug discovery, Mycobaterium tuberculosis, Ndh-2, oxidative phosphorylation",
author = "Harbut, {Michael B.} and Baiyuan Yang and Renhe Liu and Takahiro Yano and Catherine Vilch{\`e}ze and Bo Cheng and Jonathan Lockner and Hui Guo and Chenguang Yu and Franzblau, {Scott G.} and Petrassi, {H. Mike} and Jacobs, {William R.} and Harvey Rubin and Chatterjee, {Arnab K.} and Feng Wang",
year = "2018",
month = "3",
day = "19",
doi = "10.1002/anie.201800260",
language = "English (US)",
volume = "57",
pages = "3478--3482",
journal = "Angewandte Chemie - International Edition",
issn = "1433-7851",
publisher = "John Wiley and Sons Ltd",
number = "13",

}

TY - JOUR

T1 - Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity

AU - Harbut, Michael B.

AU - Yang, Baiyuan

AU - Liu, Renhe

AU - Yano, Takahiro

AU - Vilchèze, Catherine

AU - Cheng, Bo

AU - Lockner, Jonathan

AU - Guo, Hui

AU - Yu, Chenguang

AU - Franzblau, Scott G.

AU - Petrassi, H. Mike

AU - Jacobs, William R.

AU - Rubin, Harvey

AU - Chatterjee, Arnab K.

AU - Wang, Feng

PY - 2018/3/19

Y1 - 2018/3/19

N2 - The generation of ATP through oxidative phosphorylation is an essential metabolic function for Mycobaterium tuberculosis (Mtb), regardless of the growth environment. The type II NADH dehydrogenase (Ndh-2) is the conduit for electrons into the pathway, and is absent in the mammalian genome, thus making it a potential drug target. Herein, we report the identification of two types of small molecules as selective inhibitors for Ndh-2 through a multicomponent high-throughput screen. Both compounds block ATP synthesis, lead to effects consistent with loss of NADH turnover, and importantly, exert bactericidal activity against Mtb. Extensive medicinal chemistry optimization afforded the best analogue with an MIC of 90 nm against Mtb. Moreover, the two scaffolds have differential inhibitory activities against the two homologous Ndh-2 enzymes in Mtb, which will allow precise control over Ndh-2 function in Mtb to facilitate the assessment of this anti-TB drug target.

AB - The generation of ATP through oxidative phosphorylation is an essential metabolic function for Mycobaterium tuberculosis (Mtb), regardless of the growth environment. The type II NADH dehydrogenase (Ndh-2) is the conduit for electrons into the pathway, and is absent in the mammalian genome, thus making it a potential drug target. Herein, we report the identification of two types of small molecules as selective inhibitors for Ndh-2 through a multicomponent high-throughput screen. Both compounds block ATP synthesis, lead to effects consistent with loss of NADH turnover, and importantly, exert bactericidal activity against Mtb. Extensive medicinal chemistry optimization afforded the best analogue with an MIC of 90 nm against Mtb. Moreover, the two scaffolds have differential inhibitory activities against the two homologous Ndh-2 enzymes in Mtb, which will allow precise control over Ndh-2 function in Mtb to facilitate the assessment of this anti-TB drug target.

KW - antimicrobial compounds

KW - drug discovery

KW - Mycobaterium tuberculosis

KW - Ndh-2

KW - oxidative phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=85043687015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043687015&partnerID=8YFLogxK

U2 - 10.1002/anie.201800260

DO - 10.1002/anie.201800260

M3 - Article

C2 - 29388301

AN - SCOPUS:85043687015

VL - 57

SP - 3478

EP - 3482

JO - Angewandte Chemie - International Edition

JF - Angewandte Chemie - International Edition

SN - 1433-7851

IS - 13

ER -